Defective urinary crystallization inhibition and urinary stone formation
Open Access
- 1 June 2006
- journal article
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 32 (3) , 342-349
Abstract
INTRODUCTION: Nephrocalcin (NC) is a glycoprotein produced in the kidney and inhibits calcium oxalate crystal formation. It has been separated into 4 isoforms (A, B, C, and D) and found that (A + B) are more abundant than (C + D) in urine of healthy subjects, but the reverse is seen in human urine of kidney stone patients. To further examine the role of this protein in inhibition of urinary crystallization, nephrocalcin isoforms were purified from 2 genetically pure dog species. MATERIALS AND METHODS: We studied healthy Beagles, known to be non-stone forming dogs, and Mini-Schnauzers, known to be calcium oxalate stone formers. NC was isolated and purified from each group. Urinary biochemistry and calcium oxalate crystal growth inhibition were measured. RESULTS: Specific crystal growth inhibition activity was significantly higher in non-stone forming dogs (9.79 ± 2.25 in Beagles vs. 2.75 ± 1.34 of Mini-Schnauzers, p < 0.005). Dissociation constants toward calcium oxalate monohydrate were 10-fold different, with Beagles' isoforms being 10 times stronger inhibitors compare to those of Mini-Schnauzers'. Isoforms C + D of NC were the main isoforms isolated in stone-forming dogs. CONCLUSION: NC of these two species of dogs differently affects calcium oxalate crystallization and might have a role in determining ulterior urinary stone formationKeywords
This publication has 11 references indexed in Scilit:
- Changes in calcium oxalate crystal morphology as a function of supersaturationInternational braz j urol, 2004
- Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog modelUrology, 2003
- Nephrocalcin isoforms coat crystal surfaces and differentially affect calcium oxalate monohydrate crystal morphology, growth, and aggregationJournal of Crystal Growth, 2003
- Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallizationBrazilian Journal of Medical and Biological Research, 2002
- Osteopontin—a molecule for all seasonsQJM: An International Journal of Medicine, 2002
- Characterization of Ca2+-Binding Sites in the Kidney Stone Inhibitor Glycoprotein Nephrocalcin Using Vanadyl Ions: Different Metal Binding Properties in Strong and Weak Inhibitor Proteins Revealed by EPR and ENDORBiochemistry, 1996
- Increases in Urinary Inhibitor Activity and Excretion of an Inhibitor of Crystalluria in Pregnancy: A Defense Against the Hypercalciuria of Normal GestationHypertension in Pregnancy, 1993
- Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.Journal of Clinical Investigation, 1987
- Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.Journal of Clinical Investigation, 1985
- [12] Determination of total protein1983